☰

Tanya Chotibut - Publications

Affiliations: 
Louisiana State University Shreveport, Shreveport, LA, United States 
Tree Info Grants Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Chotibut T, Meadows S, Kasanga EA, McInnis T, Cantu MA, Bishop C, Salvatore MF. Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28631864 DOI: 10.1002/Mds.27077  0.589
2014 Chotibut T, Fields V, Salvatore MF. Norepinephrine transporter inhibition with desipramine exacerbates L-DOPA-induced dyskinesia: role for synaptic dopamine regulation in denervated nigrostriatal terminals. Molecular Pharmacology. 86: 675-85. PMID 25208966 DOI: 10.1124/Mol.114.093302  0.702
2014 Chotibut T, Davis RW, Arnold JC, Frenchek Z, Gurwara S, Bondada V, Geddes JW, Salvatore MF. Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model. Molecular Neurobiology. 49: 1282-92. PMID 24297323 DOI: 10.1007/S12035-013-8598-0  0.701
2012 Chotibut T, Apple DM, Jefferis R, Salvatore MF. Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake. Plos One. 7: e52322. PMID 23300642 DOI: 10.1371/Journal.Pone.0052322  0.679
2012 Salvatore MF, Davis RW, Arnold JC, Chotibut T. Transient striatal GLT-1 blockade increases EAAC1 expression, glutamate reuptake, and decreases tyrosine hydroxylase phosphorylation at ser(19). Experimental Neurology. 234: 428-36. PMID 22285253 DOI: 10.1016/J.Expneurol.2012.01.012  0.694
Show low-probability matches.